I . The 'flooding dose' technique for measuring the rate of protein synthesis in tissues in vivo involves the injection of a large amount of unlabelled amino acid together with the tracer to minimize differences in isotopic enrichment of the free amino acid in plasma and tissue compartments. This approach has been investigated in human muscle by taking biopsies from postabsorptive male volunteers given
INTRODUCTION
Many pathological states are associated with a loss of muscle protein, resulting from a change in the balance of protein synthesis and breakdown in the tissue. Until recently our understanding of the control of muscle protein synthesis and breakdown by factors such as nutrient availability, hormonal milieu, innervation and work has had to rely very heavily on studies in experimental animals. because of the difficulty of making measurements of protein turnover in human tissues. Methods were available for use in experimental animals, but these used radioactively labelled amino acids. with consequent health risks. and required that quite large amounts of tissue be sampled.
The availability of stable isotopically labelled amino acids, however, enabled Halliday & McKeran [ 11 to adapt the constant infusion technique (2, 31 for measurement of protein synthesis in human muscle. They infused ["Nllysine into young men for 20-30 h and measured the incorporation of label into protein of muscle samples taken by percutaneous biopsy. This approach has subsequently been refined by giving a primed 8 h infusion of [I-"ClIeucine 141.
Calculation o f the rate of protein synthesis from isotopic labelling experiments requires measurement of the incorporation of label into protein and the isotopic enrichment of the free amino acid at the site of protein synthesis. The latter has proved difficult in experiments in animals when the label was given as a tracer dose, as with the constant infusion method, because of compartmentation of the free amino acid in the tissue. The isotopic enrichment of the free amino acid in the plasma is different from that in the intracellular pool, and neither might be representative of the amino acid at the site of protein synthesis, i.e. aminoacyl-tRNA (see [ 51). Direct measurements on aminoacyl-tRNA demand large tissue specimens which must be handled with special caution because of the small amount of tRNA present and its extremely rapid turnover rate 161. Instead, the 'flooding dose' technique, in which the label is given together with a large amount of unlabelled amino acid, has been very widely adopted for studies of protein synthesis in cultured cells (e.g. 17 , 8]), perfused or incubated tissues in vitro (e.g. [9-111) and tissues in the intact animal it7 vivo 112-151. The theory behind this approach is that the high concentration of the free amino acid results in rapid equilibration of intra-and extra-cellular compartments, including the pool that is used for charging tRNA, to similar isotopic enrichments, thus enabling rates o f protein synthesis to be calculated with minimum error.
The advantage of prccision. in addition to the potential for rapid and convenient measurement of protein synthesis rates in human muscle under hospital conditions, encouraged us t o investigate the validity and practicality of the 'flooding dose' method in man. The present paper reports the results of a validation study in healthy volunteers given injections of 0.05 g o f I l-"C]-leucine/kg body weight.
MATERIALS AND METHODS

Materials
L-[ l-IT]Leucine (99 atom%; Tracer Technologies, Somerville, MA, U.S.A.) was dissolved in sterile water, together with sufficient unlabelled leucine (Ajinomoto Company, Tokyo, Japan) to give the required "C enrichment, to a concentration of 20 g/l. Solutions were prepared and heat sterilized at the Pharmaceutical Unit of the South Hospital, Stockholm, Sweden, and thereafter stored in sterile containers. Isomeric purity of the labelled amino acid was confirmed by gas chromatography on a 50 m WCOT fused silica column (inner diameter 0.22 mm) coated with an optically active liquid phase, XE-60-S-Val-x-Pea (Chromapak UK Ltd, London).
Subjects
Healthy male volunteers who had no known metabolic disorders were given meals of a standardized composition on the day before the study, with the last meal taken at 20.00 hours. The next morning they were studied in the postabsorptive state, starting at 07.00 hours. A cannula was inserted into one radial artery for blood sampling and another placed in a forearm vein on the opposite side for injection o f labelled leucine. Percutaneous muscle biopsies were taken under local anaesthesia from the lateral portion of the quadriceps femoris muscle, approximately 15 cm above the knee, using a Bergstrom 1161 needle. The biopsy material was dissected carefully to remove visible fat and connective tissue. Tissue specimens of 100-200 mg wet weight were used to determine the isotope enrichment of both free and protein-bound leucine, of 50-60 mg to assess the enrichment of muscle free leucine only and of 25-30 mg to measure the free amino acid concentrations. Muscle samples were weighed three times in 24 s on an automated electrobalance (Cahn 29, Cahn Instruments, Cerritos, CA, U.S.A.), and the wet weight was extrapolated to zero time. Specimens were frozen in liquid N2 within 2 min and stored at -80°C before transport to Aberdeen by air. During transport samples were packed in solid CO?.
Experimental techniques
Experiment I. A bolus injection of 4.0 g of unlabelled leucine in 200 ml was given intravenously to two subjects. Blood was sampled before and at 5, 10, 15, 20, 30, 40, 50,60,90, 120 and 180 min after the start of the injection for determination of the plasma free amino acid concentration. Muscle biopsies were taken before and at 15 and 60 min after injection in one subject and at 30 and 120 min in the other subject for measurement o f the free amino acid concentration in muscle. Table 1 . Two different levels of isotope enrichment were used: 39.0 atom% excess ( n = 3) and 19.4 atom% excess ( n = 7 ) . Blood samples for measurement of the enrichment of free leucine and KIC in plasma were taken before and at 10, 20, 30, 6 0 and 120 min after the start of injection. Muscle biopsies for measurement of the enrichment of free and protein- bound leucine were taken before and at 90 min after injection.
Ethics
The nature, purpose and potential risks of the experimental procedures were explained to the subjects before obtaining their voluntary consent. The research protocol was approved by the Ethics Committee of the Karolinska Institute, Stockholm.
Measurement of I3C enrichments
Blood samples were centrifuged and the plasma was stored at -80°C. Preparation of plasma for measurement of isotopic enrichment of free leucine and KIC was as previously described [ 171. The free and protein-bound leucine from muscle were separated by pulverizing the frozen sample between aluminium blocks cooled by solid COz, homogenizing in HCIO, (0.2 mol/l) and centrifuging [ 15, 181. The supernatant was neutralized with KOH at VC, centrifuged to remove KCIO, and used for measurement of the enrichment of free leucine. The protein precipitate was washed twice by resuspending in HCIO,, dissolved in NaOH (0.3 mol/l) at 37°C for 1 h, re-precipitated with HCIO, and the pellet given two more washes with HCIO, before hydrolysing in concentrated HCl for 24 h at 110°C. The HCI was removed by evaporation in vacuo and the sample was used for measurement of the isotopic enrichment of leucine in protein.
The enrichment of free leucine and KIC from plasma was measured by gas chromatography-mass spectrometry on a VG 12-250 quadrupole mass spectrometer (VG Masslab, Manchester). Leucine was measured as the tertiary butyldimethylsilyl derivative and KIC as the quinoxalinol tertiary butyldimethylsilyl derivative under electron-impact ionization with selective ion monitoring [ 171. The enrichment of leucine from the muscle biopsies was measured by gas chromatography-mass spectrometry using the N-heptafluorobutyryl n-butyl ester derivative under negative chemical ionization with methane as the reagent gas, by a modification of a previously described method [ 19, 201 . The enrichments of free leucine and KIC and of the injected leucine were expressed as atomo/o excess over the zero-time value.
The enrichment of leucine from the protein hydrolysate was measured along the principles outlined previously [21] . The leucine was separated by ionexchange chromatography (Locarte, London: 60 cm x 0.9 cm column), with 10% of the eluate passed to the analytical system to detect the peaks and 90% diverted to a fraction collector. The samples containing the leucine peak were combined, desalted on a cation-exchange column (Biorad 50), eluted with 4 mol/l NH,OH and evaporated to dryness in vacuo before reconstitution in 0.5 ml of 0.1 mol/l HCI. Sub-samples containing 3 pmol of leucine were evaporated to dryness in a stream of N, at 100°C in a 20 ml Vacutainer tube (red cap, Siliconecoated, sterile, no additive; Beckton Dickinson, Rutherford, NJ, U.S.A.: the batch number selected to show low interference by the contaminant at mass 46 [22] ). The tubes were placed in ice, 20 mg of ninhydrin and 1 ml of cold, degassed lithium citrate buffer (0.1 mol/l, pH 2.2) were added, the rubber septa were reintroduced (immediately after degassing at 90°C under a pressure of 10 Pa for 1 h) and the tubes were evacuated for 5 min. 13C0, was generated from the carboxyl group of leucine by heating at 100°C for 1 h, and the tube was allowed to stand at room temperature for 1 h before analysis. The I3C enrichment of the CO, was measured on a gas isotope ratio mass spectrometer (SIRA 12, VG Isogas) fitted with an automatic cryogenic purification system, and values were calculated as atom% excess by reference to a standard (Pee Dee Belemnite).
Other analytical techniques
The free Wino acid concentrations in plasma and muscle biopsies were measured by automated amino acid analysis (Alpha Plus, LKB AB, Bromma, Sweden) using lithium buffers [23] . Muscle samples were homogenized and precipitated in sulphosalicylic acid in a glass homogenizer. After centrifugation the supernatant was used for free amino acid analysis. Serum glucose was measured by a glucose dehydrogenase method [24] and serum insulin by radioimmunoassay [25] .
Calculations and statistics
from the formula previously described [ 141:
The rate of muscle protein synthesis was calculated where k, is the fractional rate of protein synthesis (%/day), P(o) and P(,) are the enrichments of leucine in muscle protein at the beginning and end of the incorporation period (atom% excess) and A is the area under the curve for precursor enrichment excess x time in days), calculated as described in the Results section.
Data are presented as mean values and SEMS. The significance of differences between means was assessed by Student's r-test.
RESULTS
Experiment 1
This was performed to verify that 4 g of leucine was sufficient to raise the plasma and muscle concentrations of leucine to high levels for an extended period. Two subjects were given injections of the amino acid and blood samples were taken sequentially over the next 3 h. Three muscle biopsies were taken from each subject: at 0, 15 and 60 min in one and at 0,30 and 120 min in the other (Fig. 1) . The plasma leucine concentration .rose very rapidly to 700-1100% of its initial value and then fell quite quickly. However, at 60 rnin values were about 300% of basal, while at 120 min concentrations were still elevated at about 200% of basal. The initial increase in concentration was much less pronounced in the muscle, but an elevation to 400% of basal was apparent at 15 min, followed by a slow decline from about 300% to 200% between 30 and 120 min.
Experiment I1
In this experiment the enrichment of free leucine in plasma and muscle after injection of [ l-"C]leucine (0.05 g/kg body weight; 4.9 atom% excess) was monitored in six subjects (Fig. 2) . After termination of the 4 rnin injection the plasma leucine enrichment was already 82 k 1% of that of the injected material. Subsequently there was an almost linear fall to 4 4 f 1% of the 5 min value at 120 min. The curve for enrichment of KIC in plasma was similar to that for leucine, but values were lower at early time points (5 and 10 min) and higher subsequently, with the cross-over point at about 15 min. The leucine in muscle biopsies taken from each subject at 10, 20, 30,60 and 120 min also reached high enrichments within the first 10 min, indicating that 'flooding' had occurred. Values for leucine in muscle were almost identical to those for the KIC and similar to those for leucine in p I a s m a.
Measurements were also made of glucose and insulin concentration in plasma (Fig. 3) . At 5 min after the start of injection the insulin concentration was elevated by about and muscle free leucine (0) in six subjects after intravenous injection of (l-13C]leucine (0.05 g/kg; 4.9 atomo/o excess) (experiment 11). Results are means f SEM.
was not altered significantly by injection of leucine at any time up to 120 min.
Experiment Ill
In this experiment the rate of protein synthesis was calculated from the difference in leucine enrichment in protein and the area under the curve for precursor enrichment between zero time and 90 rnin after injection of (1-"Clleucine (0.05 g/kg body weight; 19.4 or 38.6 atom% excess) ( Table 2 ). The areas under the curves for plasma leucine and plasma KIC enrichment between zero and 90 min demonstrate the close similarity between these two possible estimates of precursor enrichment. The calculation of area was made by assuming a linear change between successive time points. The zero-time value (immediately after the injection was started) was taken to equal the first measured value for leucine and zero for KIC, as this seemed most consistent with the curves shown in Fig. 3 . Rates of protein synthesis calculated from the plasma leucine enrichment ( 1.86 f 0.1 ~O / O / day) were 4.8 f 0 . 7 % (P<0.0001) lower than those calculated from the KIC ( 1.95 f 0.12%/day).
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DISCUSSION
In this study we have demonstrated that the rate of protein synthesis in human muscle can be measured by injecting a large dose of stable isotopically labelled amino acid to enhance equilibration of label in the free amino acid pools of plasma and tissue. This approach, using radioactively labelled amino acids, has been widely adopted for studies of protein synthesis in vitro and in vivo in systems ranging from cultured cells to small animals, but has been used in only a few larger species (pigs [26] and lambs [27]) and has not before been attempted with a stable isotope. The amount of amino acid used (0.05 g/kg body weight) was smaller than that given for measuring protein synthesis in rats (0.13 g of leucine/kg body weight [14] , 0.25 g of phenylalanine/kg body weight [ 1 S]), the exact dose being derived from experience of the method in growing lambs (P. M. Harris, P. J. Garlick & G. E. Lobley, unpublished work). This dose is similar to that given previously to study leucine hypoglycaemia (0.2 g/kg body weight as an oral dose or as an intravenous infusion over 30 min [28] ). Little effect of the leucine on plasma glucose or insulin was observed (Fig. 3) . The dose was, however, large enough to cause elevated concentrations of free leucine in plasma and muscle for 2-3 h. The volunteers reported no discomfort or other effects during or after injection.
The important criterion of 'flooding', that the enrichment in plasma and tissue free amino acids was similar, was achieved over the period 10-120 min. Only at very early times was the leucine enrichment appreciably lower in the muscle than in the plasma, representing the short time taken for the intracellular leucine in muscle to equilibrate with plasma leucine under these conditions. *Values for the three subjects given the leucine with the higher enrichment were normalized to those with the lower enrichment for the purposes of calculating the mean.
The curve for enrichment of plasma KIC was very close to that for muscle leucine, which is consistent with the evidence that the plasma KiC originates from transamination of muscle leucine [ 291. In practice, therefore, serial samples of plasma and measurement of KIC enrichment can be used to define the changes in enrichment of muscle intracellular leucine. The final procedure adopted for measuring muscle protein synthesis involved a 90 min period, with blood samples taken at 0, 10, 20, 30, 60 and 90 min and muscle biopsies at the beginning and end. The baseline of enrichment in protein (0 min) is essential, as the values varied appreciably from subject to subject (Table 2) , despite the fact that only the first one had received [ l-I3C]leucine previously. This variability probably reflects individual differences in habitual diet, since maize-and fish-derived products have a higher natural enrichment than the agricultural plants and animals of northern Europe [30] . Incorporation into protein was assessed over 90 min because elevated leucine concentrations and closely similar enrichments of leucine in plasma and muscle were maintained throughout. This period also optimized incorporation into protein and minimized the potential for error in calculating the area under the precursor curves before 10 min, during which time no direct measurements were made (see the Rcsults section). With this period the area under the plasma leucine and KIC enrichment curves differed by less than 5% (Table 2) . indicating the success of the 'flooding' procedure.
The calculated rates of muscle protein synthesis in fasted young men were 1.86%/day from plasma leucine and 1.95%/day from KIC. The difference is very small, although statistically significant. However, for consistency with studies in the literature on human muscle, which have used KIC as representative of the muscle intracellular leucine (e.g. [31] ), and on animal muscle, which have used the tissue free amino acid (e.g. [18] ), we will regard the values from KIC as more representative.
Our values are higher than the l.l%/day recently reported by Halliday and co-workers [3 1-33], from primed constant infusions of [l-13C]leucine of about 1 mg h-I kg-I, but lower than the previously reported value of 2.4%/day [4] from the same group. The higher value of 2.4%/day was obtained by infusing [ 1 -13C]leucine that was contaminated with the D-isomer [31] , but we have checked that the leucine we injected was pure L-form. The analytical techniques we used were similar to those used by Halliday et af. [31] . They have suggested that the rigorous exclusion of water from the mass spectrometer during measurement of the enrichment of CO, derived from protein-bound leucine might avoid erroneously high values [31] , but we are unable to detect any such errors in our system. They also suggested that the use of ionexchange chromatography, rather than their newly adopted gas chromatography, to separate leucine from protein hydrolysates might also have introduced an error. We have examined our technique using ion-exchange chromatography carefully and although we find fractionation of '?C and I3C across the leucine peak, as long as all of the leucine peak is collected and leucine is adequately separated from the tail of the isoleucine peak, accurate values are readily obtainable. Standard solutions containing leucine plus isoleucine when run through the complete system give the expected result for leucine enrichment at the values typically found in these experiments (e.g. 1.1 202 f 0.0003 atom% excess for five samples run through the columns compared with 1.1 198 f 0.00006 atom% excess for five samples of leucine from the same origin measured directly). Moreover, systematic errors in analysis occurring in both baseline and enriched samples would have a relatively small effect on the calculated rate of protein synthesis which is based on the difference between two measured values.
Previous studies in rats have also shown that a 'flooding dose' of leucine gives a higher rate of muscle protein synthesis than constant infusion of a tracer amount of labelled amino acid [34] . The basic principle behind the 'flooding' technique is that errors resulting from compartmentation of tissue amino acid pools should become progressively less as the amino acid concentration is raised [9], because the enrichments of free leucine in plasma and tissue approach each other and that of aminoacyl-tRNA [8, 12, 351. Thus rates of protein synthesis determined by the 'flooding' method are generally accepted to be more reliable than those obtained with tracer doses of labelled amino acids [7-9, 12,351.
Leucine was chosen for this study because it is readily available at a low price relative to other amino acids. Initially it was important to verify that flooding was possible with doses of amino acid that are acceptable for general use in man. However, high concentrations of branched-chain amino acids or leucine alone have been shown to stimulate muscle protein synthesis in a number of preparations in vitro (e.g. [ 10, 11, 361). Despite this, there is little direct evidence in man for an effect of leucine on muscle protein synthesis in vivo. Data from constant infusion of labelled leucine together with substrate quantities of unlabelled leucine have suggested an increase in whole body synthesis [37] . However, it is not possible to distinguish between a real stimulation of synthesis and an apparent effect arising from a change in precursor enrichment due to changes in leucine concentration (see above). To distinguish between these two alternatives would require an independent method for measuring protein synthesis that does not involve labelled leucine. Studies in intact animals, using a different amino acid, [-'H]phenylalanine, for measurement, have shown that leucine does not stimulate muscle protein synthesis either 10 min or 1 h after injection of a large dose [ 14, 181. Furthermore, we have recently shown that a stimulation of muscle protein synthesis in postabsorptive rats by branched-chain amino acids can be achieved, but only if the insulin concentration is also increased (381. Although the leucine injection in man resulted in a very small increase in plasma insulin (4 p-units/ml), it seems unlikely that this small and transient elevation (Fig. 3) would be sufficient to stimulate muscle protein synthesis.
We conclude that the 'flooding dose' method provides a reliable estimate of the rate of muscle protein synthesis in man. The advantages of this approach make it a potentially very valuable tool for studying the regulation of protein synthesis in volunteers or patients in v i v a In addition to enhanced precision, it is relatively simple and convenient to operate within the context of a hospital environment. It does not require patient or staff participation for inconveniently long periods and a steady state with respect to the rate of protein synthesis needs to be maintained for only 90 min. With the constant infusion technique it is important to maintain plateau enrichment in the plasma leucine throughout a more lengthy protocol, and this might be distorted by food intake, drug and other treatments or anaesthesia. Finally, the short period of measurement with the 'flooding dose' method makes it suitable for studying both the long-term (e.g. endocrine disorders, trauma) and the acute (e.g. feeding, insulin) factors that regulate protein synthesis.
